Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Robert Lucas

Physician Assistant Florence, AL Physician Assistant

NPI 1376172981 CMS profile 11387537

1751 Veterans Dr Ste 300, Florence, AL 35630

Open in the dashboard

General payments

$171

7 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Lucas of Florence, AL is reported in the CMS Open Payments database as having received $171 across 7 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 36th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $86 3
2023 General $55 2
2022 General $30 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Lucas
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Robert Lucas were reported at $86. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Robert Lucas Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $30 $155 $48–$522 $149
2023 $55 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $86 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. DePuy Synthes Sales Inc. $37 1 payment
  2. Pacira Pharmaceuticals Incorporated $32 1 payment
  3. Ferring Pharmaceuticals Inc. $31 1 payment
  4. Solventum Corporation $22 1 payment
  5. Smith+Nephew, Inc. $18 1 payment
  6. AbbVie, Inc. $15 1 payment
  7. Heron Therapeutics, Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $171 7 payments
Products named General payments · program years 2022–2025
  1. MONOVISC $37 1 payment
  2. Iovera $32 1 payment
  3. Zilretta $32 1 payment
  4. Exparel $32 1 payment
  5. EUFLEXXA $31 1 payment
  6. PREVENA $22 1 payment
  7. V.A.C. VERAFLO $22 1 payment
  8. ACTIV.A.C. $22 1 payment
  9. RENASYS GO v2 HOME $18 1 payment
  10. DALVANCE $15 1 payment
  11. Other $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

722

Median for Physician Assistant: 241

Drug cost

$4,463

Median for Physician Assistant: $4,110

Branded share of claims

27.4%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 171 $1,273
Methylprednisolone Generic 140 $1,043
Meloxicam Generic 185 $547
Clindamycin Hcl Generic 25 $469
Ibuprofen Generic 28 $261
Diclofenac Sodium Generic 14 $177
Nabumetone Generic 14 $172
Tramadol Hcl Generic 44 $160
Tizanidine Hcl Generic 58 $160
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 27 $134

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 107 billing codes

Paid by Medicare

$60,193

Of which drugs: $1,733

Medicare patients

399

Average age 74

Services billed

2,086

266 women, 133 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 39%
Depression 31%
Ischemic heart disease 29%
Chronic kidney disease 24%
COPD 20%
Atrial fibrillation 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 114 342 $1,568
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 29 148 $116
Injection, ketorolac tromethamine, per 15 mg J1885 Office 24 93 $39

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

7 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record